The findings and impact of nonrehydrated guaiac examination of the rectum (FINGER) study: A comparison of 2 methods of screening for colorectal cancer in asymptomatic average-risk patients

Archives of Internal Medicine

Volumn 159, Issue 17, 1999, Pages 2022-2026

  Bini, Edmund J ^a,b   Rajapaksa, Roshini C ^a   Weinshel, Elizabeth H ^a  

^a BELLEVUE HOSPITAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUAIAC;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FINGER; HEALTH CARE COST; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICAL RECORD; OCCULT BLOOD TEST; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RECTUM; REIMBURSEMENT;

COLONOSCOPY; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK;

EID: 0033610233     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.17.2022     Document Type: Article

References (24)

1. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365-1371.
2. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996; 348:1467-1471.
3. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472-1477.
4. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin. 1998;48:6-29.
5. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594-642.
6. Byers T, Levin B, Rothenberger D, Dodd GD, Smith RA. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997: American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. CA Cancer J Clin. 1997;47:154-160.
7. Gomez JA, Diehl AK. Admission stool guaiac test: use and impact on patient management. Am J Med. 1992;92:603-606.
8. Lieberman DA. Colon cancer screening: the dilemma of positive screening tests. Arch Intern Med. 1990;150:740-744.
9. Longstreth GF. Checking for "the occult" with a finger: a procedure of little value. J Clin Gastroenterol. 1988;10:133-134.
10. Rex DK. Colonoscopy: a review of its yield for cancers and adenomas by indication. Am J Gastroenterol. 1995;90:353-365.
11. Ahlquist DA. Occult blood screening: obstacles to effectiveness. Cancer. 1992; 70:1259-1265.
12. Hardcastle JD, Thomas WM, Chamberlain J, et al. Randomised, controlled trial of faecal occult blood screening for colorectal cancer: results for first 107,349 subjects. Lancet. 1989;1:1160-1164.
13. Trehu EG, Cooper JN. Cost of screening for colorectal cancer: results of a community mass screening program and review of the literature. South Med J. 1992; 85:248-254.
14. Simon JB. Occult blood screening for colorectal cancer: a critical review. Gastroenterology. 1985;88:820-837.
15. Eisner MS, Lewis JH. Diagnostic yield of a positive fecal occult blood test found on digital rectal examination: does the finger count? Arch Intern Med. 1991;151: 2180-2184.
16. Brint SL, DiPalma JA, Herrera JL. Is a Hemoccult-positive rectal examination clinically significant? South Med J. 1993;86:601-603.
17. Rockey DC, Koch J, Cello JP, Sanders LL, McQuaid KR. Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests. N Engl J Med. 1998;339:153-159.
18. Bini EJ, Valdes MT, Weinshel EH. Predictive value of a positive fecal occult blood test for upper gastrointestinal lesions in asymptomatic patients with a negative colonoscopy [abstract]. Gastrointest Endosc. 1998;47:AB80.
19. Thomas WM, Hardcastle JD. Role of upper gastrointestinal investigations in a screening study for colorectal neoplasia. Gut. 1990;31:1294-1297.
20. Zuckerman GR, Benitez J. A prospective study of bidirectional endoscopy (colonoscopy and upper endoscopy) In the evaluation of patients with occult gastrointestinal bleeding. Am J Gastroenterol. 1992;87:62-66.
21. Hsia PC, Al-Kawas FH. Yield of upper endoscopy in the evaluation of asymptomatic patients with Hemoccult-positive stool after a negative colonoscopy. Am J Gastroenterol. 1992;87:1571-1574.
22. Geller AJ, Kolts BE, Achem SR, Wears R. The high frequency of upper gastrointestinal pathology in patients with fecal occult blood and colon polyps. Am J Gastroenterol. 1993;88:1184-1187.
23. Chen YK, Gladden DR, Kestenbaum DJ, Collen MJ. Is there a role for upper gastrointestinal endoscopy in the evaluation of patients with occult blood-positive stool and negative colonoscopy? Am J Gastroenterol, 1993;88:2026-2029.
24. Ransohoff DF, Lang CA. Screening for colorectal cancer. N Engl J Med, 1991; 325:37-41.